Prevention and Treatment of Thromboembolic and Ischemic Complications Associated with Endovascular Procedures: Part I???Pathophysiological and Pharmacological Features
Open Access
- 1 June 2000
- journal article
- review article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 46 (6) , 1344-1359
- https://doi.org/10.1097/00006123-200006000-00012
Abstract
Thromboembolic and ischemic complications frequently occur during and after endovascular procedures, because of associated arterial injury and the thKeywords
This publication has 119 references indexed in Scilit:
- Rationale for low–molecular weight heparin in coronary stentingAmerican Heart Journal, 1997
- Successors to heparin: New antithrombotic agentsAmerican Heart Journal, 1997
- Antiplatelet therapy: Do the new platelet inhibitors add significantly to the clinicl benefits of aspirin?American Heart Journal, 1997
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study.Stroke, 1993
- A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk PatientsNew England Journal of Medicine, 1989
- Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplastyAmerican Heart Journal, 1989
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980
- Nonoperative Dilatation of Coronary-Artery StenosisNew England Journal of Medicine, 1979
- Scanning electron microscopy of surface irregularities and thrombogenesis of polyurethane and polyethylene coronary catheters.Circulation, 1976